Abstract
This paper is a review about the relationship between epilepsy and cognitive impairment as well. Also, the antiepileptic drugs interaction on memory, skills, mood, etc.
References
Engel J, Taylor DC. Neurobioly of behaviour disorder. In: Engel J, Pedley T. Epilepsy a Comprehensive Texbook. Philadelphia: Lippincott Raven press; 1997:2045-2052
Johnston M. Neurotransmitters and epilepsy. In: Wyllie E. The Treatment of epilepsy: principles and practice. Philadelphia: Lea & Febiger; 1993: 111-125.
Seidenberg M, O’Leary D, Berent S, Boll T. Changes in Seizure Frecuency and Test-Retest Scores on the Wechsler Adult Intelligence Scale. Epilepsia 1981, 22; 75-83
Dodril CB. Neuropsychological effects of seizures, Epilepsy & Behavior 2004; S21-S24
Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic Epilepsy and Cognition: A Longitudinal Study in Temporal Lobe Epilepsy. Ann Neurol 2003; 54:425-432
Bourgeois BDF, Prensky AL, Palkes HS, Talent BK Buxsh SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983; 14: 438-44
Bourgeois BDF. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004; Suppl 1: S15-24
Besug FMC. Reading abilities on cognitive functions of chidren with epilepsy: influence of epileptic syndromes. Brain Dev 2006; 28: 122-30
Lindgren S, Kihlgren M, Melin L, et al. Development of cognitive functions in children with rolandic epilepsy. Epilepsy & Behavior 2004; 5: 903-10
Ortinski P, Kimford MD. Cognitive side effects of antiepileptic drugs. Epilepsy & Behavior 2003; S60-65
Glauser TA. Topiramate. Epilepsia 1999; 40: S71-S80.
Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005; 64:792-798
Werz MA, Schoenberg MR, Meador KJ, Loring DW, Ray PG. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behaviour functioning. Epilepsy & Behavior 2006; 8: 181-191
Lamotrigine for generalized seizures associated with Lennox-gastaut syndrome NEJM 1997; 337: 1807-1812
Aldenkamp A, De Krom M, Reijs R. Newer Antiepileptic drugs and cognitive issues. Epilepsia 2003: 44: 21-29.
Morris GL. Gabapentin. Epilepsia 1999; 40: S63-S70.
Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is binding site for the antiepileptic drug levetiracetam. PANS 2004; 101(26):9861-66.
Cramer JA, Van Hammee K et al. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy & Behavior 2003; 4: 118-123.
French SJ, Fought E, et al. Practice advisory: that use of felbamato in treatment of patients with intractable epilepsy. Epilepsia 1999; 40: 803-808.
Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy & Behavior 2004; 5: S66-S76.
Honny A, Litzinger MJ. Tiagabine add-on treatment improves neurobehavioral and epilepsy-related syntoms in pediatric seizures patients. Epilepsia 1997;38: S208.
Livingston J, Beaumont D, et al. Vigabatrin in the treatment of epilepsy in children. Br J. Clin Pharmacol 1989; 27:1095-1125.
Aldenkamp AP, Alpherts WC. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 2006; 47(7): 1153-1159.
Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cognition. Lancet 2004;3(11): 663-672.
Kalviainen R. Cognitive effects of GABAergic antiepileptics drugs. Electroencephalografhy and clinical neurophysiology. 1997;103: 51-59.
Willmore LJ, UedaY. Molecular biology on genetics of epilepsy. Acta Med Okayana 2002; 56(2): 57-58.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.